Johnson & Johnson JNJ

JNJ Company Overview

Johnson & Johnson (NYSE: JNJ) is a diversified healthcare company operating across the pharmaceutical and medical technology industries. The company develops, manufactures, and markets products focused on immunology, oncology, neuroscience, cardiovascular disease, surgery, orthopedics, and vision care. Following the separation of its consumer health business into Kenvue in 2023, Johnson & Johnson’s primary revenue drivers are now its Innovative Medicine and MedTech segments. The company serves hospitals, healthcare systems, physicians, distributors, governments, and patients globally, with significant exposure to both developed and emerging healthcare markets.

Johnson & Johnson traces its origins to 1886, when it was founded by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey. Historically known for consumer healthcare products alongside pharmaceuticals and medical devices, the company evolved into a more focused healthcare enterprise through decades of acquisitions, research investment, and global expansion. Its strategic positioning is supported by extensive research and development capabilities, strong global distribution networks, a diversified product portfolio, and large-scale manufacturing operations. Information regarding the company’s evolution, segment structure, and strategic transition following the Kenvue separation is consistently reflected in SEC filings, annual reports, and major financial publications.